Cargando…
Reconsidering ‘minimal risk’ to expand the repertoire of trials with waiver of informed consent for research
BACKGROUND: Progress in therapeutic research is slowed by the regulatory burden of clinical trials, which provide the best evidence for guiding treatment. There is a long delay from evidence generation to adoption, highlighting the need for designs that link evidence generation to implementation. OB...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442055/ https://www.ncbi.nlm.nih.gov/pubmed/34521663 http://dx.doi.org/10.1136/bmjopen-2020-048534 |